Examination of the usefulness of the sentinel lymph node navigation for esoagogastric junctional cancer

Examination of the usefulness of the sentinel lymph node navigation for esoagogastric junctional cancer - Examination of the usefulness of the sentinel lymph node navigation for esoagogastric junctional cancer

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030795

Enrollment

Registered

2018-01-15

Start date

2017-12-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophagogastric junctional cancer (Nishi Classification)

Interventions

Sentinel lymph node navigation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) age20-80 2) cT1-T3N0-1 histological proven junctional cancer (Nishi classification) 3) untreated preoperatively (except for endoscopic resection) 4)ECOG PS0-1 5)capable of oral intake 6)written informed consent

Exclusion criteria

Exclusion criteria: 1)pregnant and to have hisory of drug allergy or the asthma. 2)to have history of treatment for other cancer within 5 years (except for the cases that undergone endoscopic radical resection) 3) untreated other cancers 4) uncontrollable organ failure 5) active infectious diseases 6) Decison as adequate cases by a donctor in charge.

Design outcomes

Primary

Measure	Time frame
Detection rate of the sentinel lymph node	—

Secondary

Measure	Time frame
Accuracy of the sentinel lymph node The rate of adverse events Sentinel lymph node identification rate distribution, metastasis situation, metastasis detectivity, Dectection rate of each of pathological type and tumor depth,	—

Countries

Japan

Contacts

Public ContactMasayuki Kano

Chiba University Frontier Surgery

mkano@chiba-u.jp043-226-2110

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026